Aqua Bio Technology (ABTEC) investor relations material

Executive summary

• Completed restructuring and refinancing, including divestments, debt-to-equity conversions, and new capital raised to establish financial stability and enable growth initiatives.

• Activity and revenue from continuing operations remained low in 1H 2026, with ongoing evaluation of business areas to strengthen results.

• Jetcarrier, a 100% owned financial investment, reported 4.8% revenue growth year-over-year and positive operating results.

Financial highlights

• Group revenue for 1H 2026 was NOK 0.3 million, down from NOK 2.2 million in 1H 2025.

• EBITDA improved to NOK -2.7 million from NOK -8.9 million year-over-year.

• Operating loss was NOK -2.8 million, compared to NOK -9.7 million in 1H 2025.

• Net loss from continuing operations was NOK -20.1 million, versus NOK -16.4 million in 1H 2025, including a NOK -9.3 million fair value loss on financial investments.

• Jetcarrier group revenue reached NOK 92.6 million, up 4.8% year-over-year.

Outlook and guidance

• Focus on consolidating operations, cost control, and exploring new growth opportunities, including potential acquisitions and partnerships.

• Jetcarrier expected to drive further growth and profitability through active tender processes.

• Continued interest in core products and ingredients, with plans to increase commercial activity.